Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Chem Biol Interact. 2024 Aug 9:111202. doi: 10.1016/j.cbi.2024.111202. Online ahead of print.
ABSTRACT
High-grade gliomas, including glioblastoma multiforme (GBM), continue to be a leading aggressive brain tumor in adults, marked by its rapid growth and invasive nature. Aldehyde dehydrogenase 1 family, member A1 (ALDH1A1), an enzyme, plays a significant role in tumor progression, yet its function in high-grade gliomas is still poorly investigated. In this study, we evaluated ALDH1A1 levels in clinical samples of GBM. We also assessed the prognostic significance of ALDH1A1 expression in GBM and LGG (low grade glioma) patients using TCGA (The Cancer Genome Atlas) database analysis. The MTT and transwell assays were utilized to examine cell growth and the invasive capability of U87 cells, respectively. We quantitatively examined markers for cell proliferation (Ki-67 and cyclin D1) and invasion (MMP2 and 9). A Western blot test was conducted to determine the downstream signaling of ALDH1A1. We found a notable increase in ALDH1A1 expression in high-grade gliomas compared to their low-grade counterparts. U87 cells that overexpressed ALDH1A1 showed increased cell growth and invasion. We found that ALDH1A1 promotes the phosphorylation of AKT, and inhibiting AKT phosphorylation mitigates the ALDH1A1’s effects on tumor growth and migration. In summary, our findings suggest ALDH1A1 as a potential therapeutic target for GBM treatment.
PMID:39128802 | DOI:10.1016/j.cbi.2024.111202
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
The Role of ALDH1A1 in Glioblastoma Proliferation and Invasion
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma Cadherin Expression Profiles Define Glioblastoma Differentiation and Patient Prognosis Deep learning-based IDH1 gene mutation prediction using histopathological imaging and clinical data The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways Immune cell infiltration and inflammatory landscape in primary brain tumours Metal-Doping Strategy for Carbon-Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma A prognostic neural epigenetic signature in high-grade glioma Comprehensive machine learning-based integration develops a novel prognostic model for glioblastoma Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA-PKcs Aldehyde dehydrogenase 1 family: A potential molecule target for diseases Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients Protective effects of silymarin in glioblastoma cancer cells through redox system regulation The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data Multi-omics and pharmacological characterization of patient-derived glioma cell lines Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis Epidemiology of malignant gliomas in Iran: first report of Iranian National Population-based Cancer Registry, 2009-2017 Extraction of Unstructured Electronic Health Records to Evaluate Glioblastoma Treatment Patterns 7 Tesla magnetic resonance spectroscopic imaging predicting IDH status and glioma grading Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells Laser interstitial thermal therapy in neurosurgery: a single-surgeon experience of 313 patients L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial Metastatic extraneural glioblastoma diagnosed with molecular testing Targeting LINC070974 inhibits lung adenocarcinoma cell proliferation and progression by interacting with Y-box binding protein 1 PET imaging of gliomas: Status quo and quo vadis? Lineage specification in glioblastoma is regulated by METTL7B Prediction of O(6)-methylguanine-DNA methyltransferase promoter methylation status in IDH-wildtype glioblastoma using MRI histogram analysis Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes Characterization of Polarimetric Properties in Various Brain Tumor Types Using Wide-Field Imaging Mueller Polarimetry Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models Deep Learning-Based Techniques in Glioma Brain Tumor Segmentation Using Multi-Parametric MRI: A Review on Clinical Applications and Future Outlooks Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications The biological significance of tumor grade, age, enhancement and extent of resection in IDH mutant gliomas: how should they inform treatment decision in the era of IDH inhibitors? Invited review Streamlined intraoperative brain tumor classification and molecular subtyping in stereotactic biopsies using stimulated Raman histology and deep learning Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma Molecular and epigenetic ex vivo profiling of testis cancer-associated fibroblasts and their interaction with germ cell tumor cells and macrophages Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma Effects of Lomerizine and Its Metabolite on Glioblastoma Cells Perioperative imaging predictors of tumor progression and pseudoprogression: a systematic review Tumor biomechanics as a novel imaging biomarker to assess response to immunotherapy in a murine glioma model The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings Speeding Up and Improving Image Quality in Glioblastoma MRI Protocol by Deep Learning Image Reconstruction Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies Identification of a single-dose, low flip angle based CBV threshold for fractional tumor burden (FTB) mapping in recurrent glioblastoma Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma Camouflaging nanoreactor traverse the blood-brain barrier to catalyze redox cascade for synergistic therapy of glioblastoma In situ brain tumor detection using a Raman spectroscopy system-results of a multicenter study Emulation and evaluation of tumor cell combined chemotherapy in isotropic/anisotropic collagen fiber microenvironments Emulation and evaluation of tumor cell combined chemotherapy in isotropic/anisotropic collagen fiber microenvironments Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI From Feeling Tough to Mental Growth: Coping with Sexual Bullying During Childhood in Gay and Bisexual Men From Feeling Tough to Mental Growth: Coping with Sexual Bullying During Childhood in Gay and Bisexual Men From Feeling Tough to Mental Growth: Coping with Sexual Bullying During Childhood in Gay and Bisexual Men
Evidence Blueprint
The Role of ALDH1A1 in Glioblastoma Proliferation and Invasion
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
The Role of ALDH1A1 in Glioblastoma Proliferation and Invasion
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/b-catenin pathway and acts as an onco-immunological biomarker Higher YAP1 Levels Are Associated With Shorter Survival of Patients With Low Grade Astrocytoma Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-b-catenin pathway Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production Cysteine induces mitochondrial reductive stress in glioblastoma through hydrogen peroxide production PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma The genomic alterations in glioblastoma influence the levels of CSF metabolites Invadopodia associated Thrombospondin-1 contributes to a post-therapy pro-invasive response in glioblastoma cells Cadherin Expression Profiles Define Glioblastoma Differentiation and Patient Prognosis Biomolecules to Biomarkers? U87MG Marker Evaluation on the Path towards Glioblastoma Multiforme Pathogenesis Deep learning-based IDH1 gene mutation prediction using histopathological imaging and clinical data Fluoxetine enhances the antitumor effect of olfactory ensheathing cell-thymidine kinase/ganciclovir gene therapy in human glioblastoma multiforme cells through upregulation of Connexin43 levels The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma The mitochondria-related gene risk mode revealed p66Shc as a prognostic mitochondria-related gene of glioblastoma AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways ALDH1A1 and ALDH1A3 paralogues of aldehyde dehydrogenase 1 control myogenic differentiation of skeletal muscle satellite cells by retinoic acid-dependent and -independent mechanisms Prognostic Value of BRAF Mutation in Glioblastoma Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts Immune cell infiltration and inflammatory landscape in primary brain tumours Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B Glycation Interferes with the Expression of Sialyltransferases and Leads to Increased Polysialylation in Glioblastoma Cells DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma The Roles of AGTRAP, ALKBH3, DIVERSIN, NEDD8 and RRM1 in Glioblastoma Pathophysiology and Prognosis Metal-Doping Strategy for Carbon-Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells A prognostic neural epigenetic signature in high-grade glioma Comprehensive machine learning-based integration develops a novel prognostic model for glioblastoma Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression Eliciting calcium transients with UV nanosecond laser stimulation in adult patient-derived glioblastoma brain cancer cells in vitro Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1 Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA-PKcs Autism patient-derived SHANK2B(Y29X) mutation affects the development of ALDH1A1 negative dopamine neuron Autism patient-derived SHANK2B(Y29X) mutation affects the development of ALDH1A1 negative dopamine neuron Aldehyde dehydrogenase 1 family: A potential molecule target for diseases A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs Stem Cell Markers in Neoplasms and their Relationship with Progression-free and Overall Survival in Patients with Recurrence Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients Protective effects of silymarin in glioblastoma cancer cells through redox system regulation The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, 68Ga-FAPI-46 PET Data, and Survival Data Multi-omics and pharmacological characterization of patient-derived glioma cell lines Quantitative assessment of preanalytic variables on clinical evaluation of PI3/AKT/mTOR signaling activity in diffuse glioma Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy Radiographic growth rate as a predictor of aggressiveness of diffuse gliomas without 1p19q codeletion Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma